A012103

OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy
Status:

Open

Trial Type:

Contact:

William Sikov, MD
wsikov@wihri.org
Stephanie Graff, MD
sgraff1@brownhealth.org